Browsing by author "Sud, Amit"
Now showing items 41-55 of 55
-
Risk of second primary cancer following myeloid neoplasia and risk of myeloid neoplasia as second primary cancer: a nationwide, observational follow up study in Sweden.
Chattopadhyay, S; Zheng, G; Sud, A; Yu, H; Sundquist, K; et al. (ELSEVIER SCI LTD, 2018-08-01)BACKGROUND: Although advances in the treatment of myeloid neoplasms have led to improved patient survival, this improvement has been accompanied by an increased risk of second primary cancer (ie, the risk of another cancer ... -
Runs of homozygosity and testicular cancer risk.
Loveday, C; Sud, A; Litchfield, K; Levy, M; Holroyd, A; et al. (WILEY, 2019-07-01)BACKGROUND: Testicular germ cell tumour (TGCT) is highly heritable but > 50% of the genetic risk remains unexplained. Epidemiological observation of greater relative risk to brothers of men with TGCT compared to sons has ... -
Second cancer risk following Hodgkin lymphoma.
Sud, A; Hemminki, K; Houlston, RS (IMPACT JOURNALS LLC, 2017-10-03) -
Second primary cancers in non-Hodgkin lymphoma: Bidirectional analyses suggesting role for immune dysfunction.
Chattopadhyay, S; Sud, A; Zheng, G; Yu, H; Sundquist, K; et al. (WILEY, 2018-11-15)Second primary cancers (SPCs) account for an increasing proportion of all cancer diagnoses. It is unlikely that prior therapy is solely responsible for SPC risk. To investigate risk of SPC after diagnosis of non-Hodgkin ... -
Second primary cancers in non-Hodgkin lymphoma: Family history and survival.
Chattopadhyay, S; Zheng, G; Sud, A; Sundquist, K; Sundquist, J; et al. (WILEY, 2020-02)Second primary cancers (SPCs) account for an increasing proportion of all cancer diagnoses and family history of cancer may be a risk factor for SPCs. Using the Swedish Family-Cancer Database on non-Hodgkin lymphoma (NHL), ... -
Second primary cancers in patients with acute lymphoblastic, chronic lymphocytic and hairy cell leukaemia.
Zheng, G; Chattopadhyay, S; Sud, A; Sundquist, K; Sundquist, J; et al. (WILEY, 2019-04-01)Improvement of survival in lymphocytic leukaemia has been accompanied by the occurrence of second primary cancer (SPCs). Based on Swedish Family Cancer Database, we applied bi-directional analyses in which relative risks ... -
Survival in hematological malignancies in the Nordic countries through a half century with correlation to treatment.
Hemminki, K; Hemminki, J; Försti, A; Sud, A (SPRINGERNATURE, 2023-04-01)Studies of survival in hematological malignancies (HMs) have generally shown an improvement over time, although most of these studies are limited by a short follow-up period. Using the NORDCAN database with data from ... -
Survivors at risk: Hodgkin lymphoma survivors at high risk of second cancers.
Sud, A (Future Medicine Ltd, 2017-06-01)Amit Sud speaks to Sebastian Dennis-Beron, Commissioning Editor: Amit Sud is a clinical research fellow in Hematology at the Institute of Cancer Research, UK. He undertook his undergraduate medical training at the University ... -
T-cell Prolymphocytic Leukemia.
Sud, A; Dearden, C (W B SAUNDERS CO-ELSEVIER INC, 2017-04-01)T-cell prolymphocytic leukemia (T-PLL) is a rare and aggressive T-cell malignancy. T-PLL can be distinguished from other lymphoid diseases by the evaluation and integration of clinical features, morphology, immunophenotyping, ... -
The clinical utility of polygenic risk scores for chronic lymphocytic leukemia.
Sud, A; Law, PJ; Houlston, RS (SPRINGERNATURE, 2021-12-01) -
Transcriptome-wide association study of multiple myeloma identifies candidate susceptibility genes.
Went, M; Kinnersley, B; Sud, A; Johnson, DC; Weinhold, N; et al. (BMC, 2019-08-20)BACKGROUND: While genome-wide association studies (GWAS) of multiple myeloma (MM) have identified variants at 23 regions influencing risk, the genes underlying these associations are largely unknown. To identify candidate ... -
Types of second primary cancers influence survival in chronic lymphocytic and hairy cell leukemia patients.
Zheng, G; Chattopadhyay, S; Sud, A; Sundquist, K; Sundquist, J; et al. (NATURE PUBLISHING GROUP, 2019-03-26) -
Utility of polygenic risk scores in UK cancer screening: a modelling analysis.
Huntley, C; Torr, B; Sud, A; Rowlands, CF; Way, R; et al. (ELSEVIER SCIENCE INC, 2023-05-10)BACKGROUND: It is proposed that, through restriction to individuals delineated as high risk, polygenic risk scores (PRSs) might enable more efficient targeting of existing cancer screening programmes and enable extension ... -
Will polygenic risk scores for cancer ever be clinically useful?
Sud, A; Turnbull, C; Houlston, R (NATURE RESEARCH, 2021-05-21)